Skip NavigationSkip to Content
Return Return to Search Results

Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis

  1. Author:
    Petraitis, V.
    Petraitiene, R.
    Solomon, J.
    Kelaher, A. M.
    Murray, H. A.
    Mya-San, C.
    Bhandary, A. K.
    Sein, T.
    Avila, N. A.
    Basevicius, A.
    Bacher, J.
    Walsh, T. J.

  2. Author Address

    NCI, Pediat Oncol Branch, Immunocompromised Host Sect, Bethesda, MD 20892 USA. SAIC Frederick Inc, Frederick, MD USA. Med Numer Inc, Sterling, VA USA. NIH, Warren Grant Magnuson Clin Ctr, Dept Radiol, Bethesda, MD 20892 USA. Kaunas Univ Med, Dept Radiol, Kaunas, Lithuania. NIH, Div Vet Resources, Off Res Serv, Bethesda, MD 20892 USA.;Walsh, TJ, NCI, Pediat Oncol Branch, Immunocompromised Host Sect, Bldg 10,CRC,Rm 1W-5740,10 Ctr Dr,MSC 1100, Bethesda, MD 20892 USA.;walsht@mail.nih.gov
    1. Year: 2006
    2. Date: Apr
  2. Journal: Antimicrobial Agents and Chemotherapy
    1. 50
    2. 4
    3. Pages: 1510-1517
  4. Type of Article: Article
  5. ISSN: 0066-4804
  1. Abstract:

    Pulmonary infiltrates in neutropenic hosts with invasive pulmonary aspergillosis are caused by vascular invasion, hemorrhagic infarction, and tissue necrosis. Monitoring the dynamics of pulmonary infiltrates of invasive aspergillosis is an important tool for assessing response to antifungal therapy. We, therefore, introduced a multidimensional volumetric imaging (MDVI) method for analysis of the response of the volume of pulmonary infiltrates over time to antifungal therapy in experimental invasive pulmonary aspergillosis (IPA) in persistently neutropenic rabbits. We developed a semiautomatic method to measure the volume of lung lesions, which was implemented as an extension of the MEDx visualization and analysis software using ultrafast computerized tomography (UFCT). Volumetric infiltrate measures were compared with UFCT reading, histopathological resolution of lesions, microbiological clearance of Aspergillus fumigatus, and galactomarman index (GMI). We also studied the MDVI method for consistency and reproducibility in comparison to UFCT. Treatment groups consisted of deoxycholate amphotericin B (DAMB) at 0.5 or 1 mg/kg of body weight/day and untreated controls (UC). Therapeutic monitoring of pulmonary infiltrates using MDVI demonstrated a significant decrease in the infiltrate volume in DAMB-treated rabbits in comparison to UC (P <= 0.001). Volumetric data by MDVI correlated with conventional CT pulmonary scores (r 0.83, P < 0.001). These results correlated with validated biological endpoints: pulmonary infarct scores (r 0.85, P <= 0.001), lung weights (r = 0.76, P <= 0.01), residual fungal burden (r = 0.65, P <= 0.05), and GMI (r = 0.78, P < 0.01). MDVI correlated with key biological markers, improved the objectivity of radiological assessment of therapeutic response to antifungal therapy, and warrants evaluation for monitoring therapeutic response in immunocompromised patients with invasive aspergillosis.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1128/aac.50.4.10-1517.2006
  3. View record in Web of Science®
  4. WOS: 000236685700053

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel